Want to see KR:002720 full AI Analyst Report?
KUKJE PHARMA Co., Ltd. (002720) Financial Statements
KUKJE PHARMA Co., Ltd. Financial Overview
KUKJE PHARMA Co., Ltd.'s market cap is currently $68.11B. The company's EPS TTM is $239.89; its P/E ratio is 13.94; and it has a dividend yield of 0.90%. KUKJE PHARMA Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 175.50B | $ 156.46B | $ 135.37B | $ 126.58B | $ 119.75B |
| Gross Profit | $ 92.97B | $ 82.50B | $ 67.22B | $ 63.25B | $ 54.47B |
| Operating Income | $ 6.18B | $ 6.70B | $ -1.99B | $ 5.27B | $ -401.29M |
| EBITDA | $ 9.41B | $ 11.02B | $ -1.04B | $ 10.23B | $ 4.08B |
| Net Income | $ 5.70B | $ 5.21B | $ -8.42B | $ 3.56B | $ -1.56B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.72B | $ 8.75B | $ 10.63B | $ 5.56B | $ 7.90B |
| Total Assets | $ 190.53B | $ 165.55B | $ 163.26B | $ 136.59B | $ 139.78B |
| Total Debt | $ 30.40B | $ 29.51B | $ 30.66B | $ 28.60B | $ 35.99B |
| Net Debt | $ 19.70B | $ 20.83B | $ 20.07B | $ 23.06B | $ 28.12B |
| Total Liabilities | $ 92.83B | $ 76.00B | $ 78.31B | $ 62.51B | $ 71.20B |
| Stockholders' Equity | $ 97.69B | $ 89.54B | $ 84.94B | $ 74.07B | $ 68.57B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.22B | $ 945.21M | $ 2.53B | $ 5.23B | $ 7.64B |
| Operating Cash Flow | $ 5.84B | $ 3.94B | $ 3.58B | $ 6.50B | $ 9.60B |
| Investing Cash Flow | $ -4.16B | $ -4.76B | $ -1.18B | $ -1.35B | $ -3.38B |
| Financing Cash Flow | $ 343.87M | $ -1.20B | $ 2.61B | $ -7.47B | $ -2.43B |
Currency in KRW